GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Gross Profit

BetterLife Pharma (STU:NPAU) Gross Profit : €0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Gross Profit?

BetterLife Pharma's gross profit for the three months ended in Jan. 2024 was €0.00 Mil. BetterLife Pharma's gross profit for the trailing twelve months (TTM) ended in Jan. 2024 was €0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. BetterLife Pharma's gross profit for the three months ended in Jan. 2024 was €0.00 Mil. BetterLife Pharma's Revenue for the three months ended in Jan. 2024 was €0.00 Mil. Therefore, BetterLife Pharma's Gross Margin % for the quarter that ended in Jan. 2024 was N/A%.

BetterLife Pharma had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage


BetterLife Pharma Gross Profit Historical Data

The historical data trend for BetterLife Pharma's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Gross Profit Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BetterLife Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BetterLife Pharma's Gross Profit

For the Biotechnology subindustry, BetterLife Pharma's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Gross Profit distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Gross Profit falls into.



BetterLife Pharma Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

BetterLife Pharma's Gross Profit for the fiscal year that ended in Jan. 2024 is calculated as

Gross Profit (A: Jan. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

BetterLife Pharma's Gross Profit for the quarter that ended in Jan. 2024 is calculated as

Gross Profit (Q: Jan. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

BetterLife Pharma's Gross Margin % for the quarter that ended in Jan. 2024 is calculated as

Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


BetterLife Pharma  (STU:NPAU) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

BetterLife Pharma had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage


BetterLife Pharma Gross Profit Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (STU:NPAU) Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines